Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Drug Alcohol Depend. 2013 Sep 1;132(1-2):387-90. doi: 10.1016/j.drugalcdep.2013.02.036. Epub 2013 May 1.
Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5.
Data from a nationally representative sample of US adults were used to compare concordance of past-year DSM-IV opioid, cannabis, cocaine and alcohol dependence with past-year DSM-5 disorders at thresholds of 3+, 4+, 5+ and 6+ positive DSM-5 criteria among past-year users of opioids (n=264), cannabis (n=1622), cocaine (n=271) and alcohol (n=23,013). Substance-specific 2 × 2 tables yielded overall concordance (kappa), sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV).
For DSM-IV alcohol, cocaine and opioid dependence, optimal concordance occurred when 4+ DSM-5 criteria were endorsed, corresponding to the threshold for moderate DSM-5 alcohol, cocaine and opioid use disorders. Maximal concordance of DSM-IV cannabis dependence and DSM-5 cannabis use disorder occurred when 6+ criteria were endorsed, corresponding to the threshold for severe DSM-5 cannabis use disorder. At these optimal thresholds, sensitivity, specificity, PPV and NPV generally exceeded 85% (>75% for cannabis).
Overall, excellent correspondence of DSM-IV dependence with DSM-5 substance use disorders was documented in this general population sample of alcohol, cannabis, cocaine and opioid users. Applicability of treatments tested for DSM-IV dependence is supported by these results for those with a DSM-5 alcohol, cocaine or opioid use disorder of at least moderate severity or severe cannabis use disorder. Further research is needed to provide evidence for applicability of treatments for persons with milder substance use disorders.
确定 DSM-IV 和 DSM-5 之间的一致性对于确定 DSM-IV 条件的治疗方法是否适用于根据 DSM-5 诊断的患者非常重要。
使用来自美国成年人的全国代表性样本的数据,比较了过去一年中使用阿片类药物(n=264)、大麻(n=1622)、可卡因(n=271)和酒精(n=23013)的过去一年使用者中,DSM-IV 阿片类药物、大麻、可卡因和酒精依赖与过去一年中 DSM-5 障碍的一致性,DSM-5 障碍的标准为 3+、4+、5+和 6+个阳性 DSM-5 标准。特定于物质的 2×2 表产生了总体一致性(kappa)、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。
对于 DSM-IV 酒精、可卡因和阿片类药物依赖,当出现 4+DSM-5 标准时,最佳一致性出现,这对应于中度 DSM-5 酒精、可卡因和阿片类药物使用障碍的阈值。DSM-IV 大麻依赖和 DSM-5 大麻使用障碍的最大一致性出现在出现 6+标准时,这对应于严重 DSM-5 大麻使用障碍的阈值。在这些最佳阈值下,敏感性、特异性、PPV 和 NPV 通常超过 85%(大麻为>75%)。
在这个酒精、大麻、可卡因和阿片类药物使用者的一般人群样本中,DSM-IV 依赖与 DSM-5 物质使用障碍之间存在极好的对应关系。对于至少中度严重或严重大麻使用障碍的 DSM-5 酒精、可卡因或阿片类药物使用障碍患者,这些结果支持对经测试用于治疗 DSM-IV 依赖的治疗方法的适用性。需要进一步的研究为轻度物质使用障碍患者的治疗方法的适用性提供证据。